Previous 10 | Next 10 |
home / stock / rvv:cc / rvv:cc news
TORONTO, Nov. 30, 2022 (GLOBE NEWSWIRE) -- REVIVE THERAPEUTICS LTD. (CSE: RVV; OTCQB: RVVTF) (“ Revive ” or the “ Company ”) is pleased to announce that it is arranging a private placement of a minimum of $3 million and up to $5 million of units (each, a &...
TORONTO, Nov. 24, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorde...
TORONTO, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorde...
TORONTO, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorde...
TORONTO, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disord...
Toronto, Ontario--(Newsfile Corp. - Le 15 septembre 2022/September 2022) - The quarterly rebalancing of the CSE 25 Index will result in the following changes, effective after the close on Friday, September 16, 2022. Le rééquilibrage trimestriel de l’indice composé du ...
TORONTO, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disord...
WHO reports 650 probable cases of acute hepatitis of unknown aetiology in children from 33 countries Company received FDA orphan drug designation for Bucillamine in the prevention of ischemia-reperfusion injury during liver transplantation and Cannabidiol for autoimmun...
Nearly $12 million in cash and investment Fully funded for the Company’s development programs, including ketamine injection and infusion product, ketamine microneedle patch and ketamine wearable pump device for mental health, neurological, and pain disorders ...
TORONTO, April 18, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disord...
News, Short Squeeze, Breakout and More Instantly...
Revive Therapeutics Ltd - Ordinary Shares Company Name:
RVV:CC Stock Symbol:
CNQC Market:
A look at the top 10 most actives in Canada Toronto-Dominion Bank (The) (TD) rose 0.2% to $78.44 on volume of 4,819,630 shares iShares Core Canadian Short Term Corporate Bond Index ETF (XSH) rose 0.1% to $18.65 on volume of 3,547,470 shares Corus Entertainment Inc. Class B Non-Voting Shar...
A look at the top 10 most actives in Canada Canadian Natural Resources Limited (CNQ) rose 2.3% to $50.13 on volume of 15,553,477 shares BetaPro Natural Gas Leveraged Daily Bull ETF (HNU) fell 11.5% to $2.93 on volume of 12,773,153 shares Toronto-Dominion Bank (The) (TD) rose 1.2% to $78.2...
A look at the top 10 most actives in Canada Toronto-Dominion Bank (The) (TD) rose 0.3% to $76.13 on volume of 16,847,005 shares Canadian Natural Resources Limited (CNQ) fell 1.5% to $48.33 on volume of 7,922,140 shares TC Energy Corporation (TRP) rose 0.1% to $51.11 on volume of 7,293,869...